Skip to main content

Overweight in Teens, Young Adults Tied to Cerebrovascular Disease in Women

Medically reviewed by Carmen Pope, BPharm. Last updated on June 6, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, June 6, 2024 -- Being overweight in adolescence or early adulthood is associated with an increased risk for cerebrovascular disease among women, according to a study published online June 6 in Stroke.

Ursula Mikkola, from the University of Oulu in Finland, and colleagues conducted a prospective cohort study to examine the effect of body mass index (BMI) and its changes in adolescence and young adulthood (ages 14 and 31 years) on early-onset cerebrovascular disease through age 54 years in a study including 10,491 people.

During follow-up, 452 individuals (4.7 percent) experienced cerebrovascular disease. The researchers found that compared with normal weight, the risk for ischemic cerebrovascular disease was increased at ages 14 and 31 years for women with overweight (hazard ratios [95 percent confidence intervals], 2.49 [1.44 to 4.31] and 2.13 [1.14 to 3.97], respectively) and obesity (hazard ratios [95 percent confidence intervals], 1.87 [0.76 to 4.58] and 2.67 [1.26 to 5.65], respectively). The results were independent of BMI at earlier or later time points. Men did not have similar associations. Women and men with obesity had an increased risk for hemorrhagic cerebrovascular disease at age 31 years (hazard ratios [95 percent confidence intervals], 3.49 [1.13 to 10.7] and 5.75 [1.43 to 23.1], respectively). At age 14 years, the risk for any cerebrovascular disease related to overweight was 2.09 times higher among girls than boys. At age 31 years, the risk for ischemic cerebrovascular disease related to obesity was 6.96 times higher among women than men.

"The association between childhood overweight and adult cerebrovascular disease is independent of overweight or obesity in adulthood, highlighting the importance for children to achieve and maintain healthy weights," the authors write.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea

FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...

Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD

THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective...

ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA

WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.